SUSAN HILSENBECK to Metformin
This is a "connection" page, showing publications SUSAN HILSENBECK has written about Metformin.
Connection Strength
0.184
-
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncol. 2023 10; 145:106536.
Score: 0.184
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.